Kaadị ule Antigen SARS-CoV-2 ngwa ngwa

Rapid 2019-nCoV IqG/IqM Combo Tost Cnrd ts nn •mmunoenromatOQraphy dabere one step in vitro tost It « d<>siQfi©d for tho fuptd Qualitative delmmlnMion of IflG nr>d IflM antitxxJios to 2019 SARS n'Coronavirus (VV. -2) na mmadu somm mmA.oc whole btood Rapid 2019-nCoV IgG/IgM Combo Tost Cnrd bụ nchọpụta nkwado maka COVID-19 BKpoctod infectod patents bosidot nudoic nod tost nke nwere ike imebi izi ezi nke tho cieloction (ma ọ bụ COVID19).

Nchịkọta

Tho ”W coronnvirusos tx>lonq to tbo P genus COVID-19 H nn nnukwu iku ume infoctous ọrịa Poop«o om Oonocnlly suscoptiWo Ugbu a, tho ndị ọrịa bu ọrịa coronavirus novel nwere bụ isi mmalite nke mfoebon.n^ywplomatic mfoefod poog cah bụrụkwa isi iyi mfoebous na nke ugbu a ©p

Ụkpụrụ

Rnpxl 2019-nCoV Combo Test Card na-eji pnnoplo nke immuno^nromotoflrap^y.Mqum ant>-mmadụ igM na òké miti human igG Aniitxxlies nro immoeniizod on tho ntfroceHutose mentxane n'otu n'otu, dị ka mmadụ abụọ tost tines (igM line aM IgG bno) na mpio ule nke ngwaọrụ ule IgM akara n'ule wndew * ctoier ka. Umple nke ọma nke IgG itnc tụpụtara dị ka obere nlele ftown site na akpụkpọ ahụ n'ime ngwaọrụ nnwale IM agba 2019-nCoV recomt>nant 90M conjugate ụdị comptexes na kpọmkwem.

ntibodios (IgM an

Enweghị tg cokxed band na mpio ule na-egosi nsonaazụ ule ne^at/vo A bwn-

Ihe Enyere

1 Raprt 2019-nCoV IgG-lgM Combo Test Card

2 Ihe nchekwa ihe atụ

2 pL capillary pipet 4 Ntuziaka maka ojiji

AKWỤKWỌ KWESỊRỊ MA Ọ BỤGHỊ

Elekere ma ọ bụ ngụ oge, lancets nchekwa, nkwadebe mmanya

Nchekwa

Chekwaa ngwaọrụ tost na 4 ruo 30 Celsius n'ime akpa onflinl solod Emela Froozo.
Ụbọchị expirabon ma ọ bụrụ>dicaie
Ngwa agaghị adị na fts akpa akpa akara akara ruo mgbe ọ dị njikere maka ojiji.Mgbe emepechara, a ga-eji ngwaọrụ nyocha ozugbo.Ejighachila ngwaọrụ ahụ.

MKPACHAPỤ ANYA

1 Maka ọkachamara in vitro diagnostic anyị naanị

2 Ngwaahịa •$ stncUy maka ọkachamara ahụike u$e naanị tod 曲 mwoded maka ojiji nkeonwe

3 Ejila ngwaahịa ya gafere ụbọchị exprsbon

4 Emela ngwaahịa ahụ ma ọ bụrụ na akpa ahụ ，$ darnaged ma ọ bụ tM $«ai bụ txoken

5 Jikwaa ụdịdị niile dịka enwere ike ibute ọrịa

6 Soro ọkọlọtọ Lat> usoro aM tMOsafety fluxMhnet maka na mkpofu potemiaii/ na-efe efe.

ihe Mgbe emechara usoro nyocha, dispo&e specimens after autoclaving na 121P kx opekata mpe 20 nke ọgwụgwọ na 0 5% Sodium HypochJonte f

NKWUKWU NKWUKWU ANO Nkwadebe

1 Serum, plasma ma ọ bụ ọbara zuru oke kwesịrị ịbụ ọnọdụ coliedod uruSer ọkọlọtọ iatxxatory ọnọdụ.

2 Heat inacbvatKX) nke ụdị, wtuch nwere ike ịkpata hemolyse na proton denaturation, kwesịrị izere.

3 Nnwale ahụ na-arụ ọrụ kacha mma na ọbara ọhụrụ / serum i plasma sample Ọ bụrụ na enweghị ike ịme nnwale ozugbo, enwere ike ịchekwa serum I plasma na 2-8ºC ruo ụbọchị 3 ma ọ bụrụ na (Nlele ule maka nchekwa ogologo oge). Enwere ike ịjụ oyi speamens serum / plasma na 20*C lor 3 months ma ọ bụ 70°C tef ogologo ogologo penod Zere cycle freezjng/thavwng ugboro ugboro.

4 Sodium az>de nwere ike ịgbakwunye dị ka ihe nchekwa ruo 0.1% na-emetụtaghị nsonaazụ ule.